201～300

201. Salustri A, Spitaels S, McGhie J, et al. Transthoracic threedimensional echocardiography in adult patints with congenital heart disease. J Am Coll

Cardiol 1995; 26: 759-767.

202. Kardon RE, Cao QL, Masani N, et al. New insights and observations in three-dimensional echocardiographic visualization of ventricular septal defects:

experimental and clinical studies. Circulation 1998; 98: 1307-1314.

203. Maeno YV, Benson LN, McLaughlin PR, et al. Dynamic morphology of the secundum atrial septal defect evaluated by three dimensional

transoesophageal echocardiography. Heart 1999; 81: 661-668.

204. De Castro S, Caselli S, Papetti F, et al. Feasibility and clinical impact of live three-dimensional echocardiography in the management of congenital

heart disease. Echocardiography 2006; 23: 553-561.

205. Takahashi K, Mackie AS, Rebeyka IM, et al. Twodimensional versus transthoracic real-time three-dimensional echocardiography in the evaluation of

the mechanisms and sites of atrioventricular valve regurgitation in a congenital heart disease population. J Am Soc Echocardiogr 2010; 23: 726-734.

206. van den Bosch AE, Robbers-Visser D, Krenning BJ, et al. Real-time transthoracic three-dimensional echocardiographic assessment of left ventricular

volume and ejection fraction in congenital heart disease. J Am Soc Echocardiogr 2006; 19: 1-6.

207. Soriano BD, Hoch M, Ithuralde A, et al. Matrix-array 3-dimensional echocardiographic assessment of volumes, mass, and ejection fraction in young

pediatric patients with a functional single ventricle: a comparison study with cardiac magnetic resonance. Circulation 2008; 117: 1842-1848.

208. Niemann PS, Pinho L, Balbach T, et al. Anatomically oriented right ventricular volume measurements with dynamic three-dimensional

echocardiography validated by 3-Tesla magnetic resonance imaging. J Am Coll Cardiol 2007; 50: 1668-1676.

209. van der Zwaan HB, Helbing WA, Boersma E, et al. Usefulness of real-time three-dimensional echocardiography to identify right ventricular dysfunction

in patients with congenital heart disease. Am J Cardiol 2010; 106: 843-850.

210. 循環器病の診断と治療に関するガイドライン．感染性心内膜炎の予防と治療に関するガイドライン（2008年改訂版）．

http://www.j-irc.or.jp/guideline/pdf/JCS2008_miyatake_h.pdf

211. Diller GP, Dimopoulos K, Okonko D, et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic

implication. Circulation 2005; 112: 828-835.

212. Motoki N, Ohuchi H, Miyazaki A, et al. Clinical profiles of adult patients with single ventricular physiology. Circ J 2009; 73: 1711-1716.

213. Harrison DA, Liu P, Walters JE, et al. Cardiopulmonary function in adult patients late after Fontan repair. J Am Coll Cardiol 1995; 26: 1016-1021.

214. Davlouros PA. Karatza AA. Gatzoulis MA, et al. Timing and type of surgery for severe pulmonary regurgitation after repair of tetralogy of Fallot. Int J

Cardiol 2004; 97 (Suppl 1): 91-101.

215. Wasserman K, Hansen JE, Sue DY, et al. eds. Principles in exercise testing and interpretation. Lea & Febiger 1994.

216. Chomsky DB. Lang CC. Rayos GH, et al. Hemodynamic exercise testing. A valuable tool in the selection of cardiac transplantation candidates.

Circulation 1996; 94: 3176-3183.

217. Ohuchi H, Takasugi H, Ohashi H, et al. Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities

patients with congenital heart disease. Circulation 2003; 108: 2368-2376.

218. Inai K, Nakanishi T, Nakazawa M. Clinical correlation and prognostic predictive value of neurohumoral factors in patients late after the Fontan

operation. Am Heart J 2005; 150: 588-594.

219. Gratz A, Hess J, Hager A. Self-estimated physical functioning poorly predicts actual exercise capacity in adolescents and adults with congenital heart

disease. Eur Heart J 2009; 30: 497-504.

220. Giannuzzi P, Temporelli PL, Corra U, et al. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of

the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVDCHF) Trial. Circulation 2003; 108: 554-559.

221. Rhodes J, Curran TJ, Camil L, et al. Impact of cardiac rehabilitation on the exercise function of children with serious congenital heart disease.

Pediatrics 2005; 116: 1339-1345.

222. Thaulow E, Fredriksen PM. Exercise and training in adults with congenital heart disease. Int J Cardiol 2004; 97 (Suppl 1): 35-38.

223. Ohuchi H, Nakajima T, Kawade M, et al. Measurement and validity of the ventilatory threshold in patients with congenital heart disease. Pediatr Cardiol

1996; 17: 7-14.

224. Tanabe K, Yamamoto A, Suzuki N, et al. Physiological role of endothelin-1 in nonworking muscles during exercise in healthy subjects. Jpn Circ J

2000; 64: 27-31.

225. Fratz S, Hess J, Schuhbaeck A, et al. Routine clinical cardiovascular magnetic resonance in paediatric and adult congenital heart disease: patients,

protocols, questions asked and contributions made. J Cardiovasc Magn Reson 2008; 10: 46.

226. Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report.

Eur Heart J 2004; 25: 1940-1965.

227. Kramer CM, Barkhausen J, Flamm SD, et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular

magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 2008; 10: 35.

228. The clinical role of magnetic resonance in cardiovascular disease. Task Force of the European Society of Cardiology, in collaboration with the

Association of European Paediatric Cardiologists. Eur Heart J 1998; 19: 19-39.

229. Marcotte F, Poirier N, Pressacco J, et al. Evaluation of adult congenital heart disease by cardiac magnetic resonance imaging. Congenit Heart Dis

2009; 4: 216-230.

230. Kilner PJ, Geva T, Kaemmerer H, et al. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the

respective working groups of the European Society of Cardiology. Eur Heart J 2010; 31: 794-805.

231. Mooij CF, de Wit CJ, Graham DA, et al. Reproducibility of MRI measurements of right ventricular size and function in patients with normal and dilated

ventricles. J Magn Reson Imaging 2008; 28: 67-73.

232. Alfakih K, Plein S, Thiele H, et al. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state

free precession imaging sequences. J Magn Reson Imaging 2003; 17: 323-329.

233. Lorenz CH. The range of normal values of cardiovascular structures in infants, children, and adolescents measured by magnetic resonance imaging.

Pediatr Cardiol 2000; 21: 37-46.

234. Dodge-Khatami A, Tulevski, II, Bennink GB, et al. Comparable systemic ventricular function in healthy adults and patients with unoperated congenitally

corrected transposition using MRI dobutamine stress testing. Ann Thorac Surg 2002; 73: 1759-1764.

235. Helbing WA, Rebergen SA, Maliepaard C, et al. Quantification of right ventricular function with magnetic resonance imaging in children with normal

hearts and with congenital heart disease. Am Heart J 1995; 130: 828-837.

236. Oshinski JN, Parks WJ, Markou CP, et al. Improved measurement of pressure gradients in aortic coarctation by magnetic resonance imaging.

J Am Coll Cardiol 1996; 28: 1818-1826.

237. Nielsen JC, Powell AJ, Gauvreau K, et al. Magnetic resonance imaging predictors of coarctation severity. Circulation 2005; 111: 622-628.

238. John AS, Dill T, Brandt RR, et al. Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic

standards? J Am Coll Cardiol 2003; 42: 519-526.

239. Steffens JC, Bourne MW, Sakuma H, et al. Quantification of collateral blood flow in coarctation of the aorta by velocity encoded cine magnetic

resonance imaging. Circulation 1994; 90: 937-943.

240. Didier D, Ratib O, Beghetti M, et al. Morphologic and functional evaluation of congenital heart disease by magnetic resonance imaging. J Magn Reson

Imaging 1999; 10: 639-655.

241. Hundley WG, Li HF, Lange RA, et al. Assessment of left-to-right intracardiac shunting by velocity-encoded, phasedifference magnetic resonance

imaging. A comparison with oximetric and indicator dilution techniques. Circulation 1995; 91: 2955-2960.

242. Debl K, Djavidani B, Buchner S, et al. Quantification of left-to-right shunting in adult congenital heart disease: phasecontrast cine MRI compared with

invasive oximetry. Br J Radiol 2009; 82: 386-391.

243. Bell A, Beerbaum P, Greil G, et al. Noninvasive assessment of pulmonary artery flow and resistance by cardiac magnetic resonance in congenital

heart diseases with unrestricted left-to-right shunt. JACC Cardiovasc Imaging 2009; 2: 1285-1291.

244. Chan KM, Wage R, Symmonds K, et al. Towards comprehensive assessment of mitral regurgitation using cardiovascular magnetic resonance.

J Cardiovasc Magn Reson 2008; 10: 61.

245. Grosse-Wortmann L, Al-Otay A, Yoo SJ. Aortopulmonary collaterals after bidirectional cavopulmonary connection or Fontan completion: quantification

with MRI. Circ Cardiovasc Imaging 2009; 2: 219-225.

246. Geva T, Greil GF, Marshall AC, et al. Gadoliniumenhanced 3-dimensional magnetic resonance angiography of pulmonary blood supply in patients with

complex pulmonary stenosis or atresia: comparison with x-ray angiography. Circulation 2002; 106: 473-478.

247. Greil GF, Powell AJ, Gildein HP, et al. Gadoliniumenhanced three-dimensional magnetic resonance angiography of pulmonary and systemic venous

anomalies. J Am Coll Cardiol 2002; 39: 335-341.

248. McConnell MV, Ganz P, Selwyn AP, et al. Identification of anomalous coronary arteries and their anatomic course by magnetic resonance coronary

angiography. Circulation 1995; 92: 3158-3162.

249. Taylor AM, Thorne SA, Rubens MB, et al. Coronary artery imaging in grown up congenital heart disease: complementary role of magnetic resonance

and x-ray coronary angiography. Circulation 2000; 101: 1670-1678.

250. Bluemke DA, Achenbach S, Budoff M, et al. Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed

tomography angiography: a scientific statement from the american heart association committee on cardiovascular imaging and intervention of the

council on cardiovascular radiology and intervention, and the councils on clinical cardiology and cardiovascular disease in the young. Circulation 2008;

118: 586-606.

251. Prakash A, Powell AJ, Krishnamurthy R, Geva T. Magnetic resonance imaging evaluation of myocardial perfusion and viability in congenital and

acquired pediatric heart disease. Am J Cardiol 2004; 93: 657-661.

252. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Circulation 1999; 100: 1992-2002.

253. Moon JC, Reed E, Sheppard MN, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic

cardiomyopathy. J Am Coll Cardiol 2004; 43: 2260-2264.

254. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol

2006; 48: 1977-85.

255. Shellock FG, Spinazzi A. MRI safety update 2008: part 1, MRI contrast agents and nephrogenic systemic fibrosis. AJR Am J Roentgenol 2008; 191:

1129-1139.

256. Roguin A, Schwitter J, Vahlhaus C, et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace

2008; 10: 336-346.

257. Crean A. Cardiovascular MR and CT in congenital heart disease. Heart 2007; 93: 1637-47.

258. Wiant A, Nyberg E, Gilkeson RC. CT evaluation of congenital heart disease in adults. AJR Am J Roentgenol 2009; 193: 388-396.

259. Kim YH, Marom EM, Herndon JE, 2nd, et al. Pulmonary vein diameter, cross-sectional area, and shape: CT analysis. Radiology 2005; 235: 43-9,

discussion 49-50.

260. Vavas E, Rosenzweig BP, Meyer DB, et al. Total anomalous pulmonary venous connection in an adult: comprehensive multimodality evaluation.

Congenit Heart Dis 2009; 4: 384-386.

261. Lee EY, Siegel MJ, Hildebolt CF, et al. MDCT evaluation of thoracic aortic anomalies in pediatric patients and young adults: comparison of axial,

multiplanar, and 3D images. AJR Am J Roentgenol 2004; 182: 777-784.

262. 循環器病の診断と治療に関するガイドライン．冠動脈病変の非侵襲的診断法に関するガイドライン．Circ J 2009； 73, Suppl. Ⅲ：1019-1089.

263. Beier UH, Jelnin V, Jain S, Ruiz CE. Cardiac computed tomography compared to transthoracic echocardiography in the management of congenital

heart disease. Catheter Cardiovasc Interv 2006; 68: 441-449.

264. Castaner E, Gallardo X, Rimola J, et al. Congenital and acquired pulmonary artery anomalies in the adult: radiologic overview. Radiographics 2006; 26:

349-371.

265. Ou P, Celermajer DS, Calcagni G, et al. Three-dimensional CT scanning: a new diagnostic modality in congenital heart disease. Heart 2007; 93: 908-

913.

266. Greil GF, Schoebinger M, Kuettner A, et al. Imaging of aortopulmonary collateral arteries with high-resolution multidetector CT. Pediatr Radiol 2006;

36: 502-509.

267. Shi H, Aschoff AJ, Brambs HJ, et al. Multislice CT imaging of anomalous coronary arteries. Eur Radiol 2004; 14: 2172-2181.

268. Bhatti S, Hakeem A, Ahmad U, et al. Persistent left superior vena cava (PLSVC) with anomalous left hepatic vein drainage into the right atrium: role of

imaging and clinical relevance. Vasc Med 2007; 12: 319-324.

269. Goo HW, Park IS, Ko JK, et al. Computed tomography for the diagnosis of congenital heart disease in pediatric and adult patients. Int J Cardiovasc

Imaging 2005; 21: 347-365.

270. Leschka S, Oechslin E, Husmann L, et al. Pre- and postoperative evaluation of congenital heart disease in children and adults with 64-section CT.

Radiographics 2007; 27: 829-846.

271. Spevak PJ, Johnson PT, Fishman EK. Surgically corrected congenital heart disease: utility of 64-MDCT. AJR Am J Roentgenol 2008; 191: 854-861.

272. Einstein AJ, Henzlova MJ, Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary

angiography. JAMA 2007; 298: 317-323.

273. Gerber TC, Carr JJ, Arai AE, et al. Ionizing radiation in cardiac imaging: a science advisory from the American Heart Association Committee on

Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular

Radiology and Intervention. Circulation 2009; 119: 1056-1065.

274. 近藤千里．小児心血管画像検査の放射線被曝リスクの考え方．日本小児循環器学会雑誌 2009；25：625-664.

275. 日本腎臓病学会編．エビデンスに基づくCKDガイドライン 2009：東京医学社 2009.

276. Dittrich S, Haas NA, Buhrer C, et al. Renal impairment in patients with long-standing cyanotic congenital heart disease. Acta Paediatr 1998; 87: 949-

954.

277. Sobic-Saranovic DP, Pavlovic SV, Jovanovic IV, et al Evaluation of myocardial perfusion and function by gated single-photon emission computed

tomography technetium-99m methoxyisobutylisonitrile in children and adolescents with severe congenital heart disease. Nucl Med Commun; 31:

12-21.

278. Chen ML, Lo HS, Su HY, et al. Coronary artery fistula: assessment with multidetector computed tomography and stress myocardial single photon

emission computed tomography. Clin Nucl Med 2009; 34: 96-98.

279. Chen ML, Lo HS, Chao IM, et al. Dipyridamole Tl-201 myocardial single photon emission computed tomography in the functional assessment of

anomalous left coronary artery from the pulmonary artery. Clin Nucl Med 2007; 32: 940-943.

280. Sato F, Koishizawa T. Stress/Rest (99m)Tc-MIBI SPECT and 123I-BMIPP scintigraphy for indication of surgery with coronary artery to pulmonary

artery fistula. Int Heart J 2005; 46: 355-361.

281. Acar P, Maunoury C, Bonnet D, et al. Comparison of myocardial perfusion single-photon emission computed tomography with coronary artery

angiography after arterial switch operation. Am J Cardiol 2001; 87: 1425-1427.

282. Hauser M, Bengel FM, Kuhn A, et al. Myocardial blood flow and flow reserve after coronary reimplantation in patients after arterial switch and ross

operation. Circulation 2001; 103: 1875-1880.

283. Hauser M, Bengel FM, Hager A, et al. Impaired myocardial blood flow and coronary flow reserve of the anatomical right systemic ventricle in patients

with congenitally corrected transposition of the great arteries. Heart 2003; 89: 1231-1235.

284. Hornung TS, Bernard EJ, Jaeggi ET, et al. Myocardial perfusion defects and associated systemic ventricular dysfunction in congenitally corrected

transposition of the great arteries. Heart 1998; 80: 322-326.

285. Lubiszewska B, Gosiewska E, Hoffman P, et al. Myocardial perfusion and function of the systemic right ventricle in patients after atrial switch

procedure for complete transposition: long-term follow-up. J Am Coll Cardiol 2000; 36: 1365-1370.

286. Brunken RC, Perloff JK, Czernin J, et al. Myocardial perfusion reserve in adults with cyanotic congenital heart disease. Am J Physiol Heart Circ

Physiol 2005; 289: H1798-806.

287. Ban K, Nakajima T, Iseki H, et al. Evaluation of global and regional left ventricular function obtained by quantitative gated SPECT using 99mTc-

tetrofosmin for left ventricular dysfunction. Intern Med 2000; 39: 612-627.

288. Boogers MM, Van Kriekinge SD, Henneman MM, et al. Quantitative gated SPECT-derived phase analysis on gated myocardial perfusion SPECT

detects left ventricular dyssynchrony and predicts response to cardiac resynchronization therapy. J Nucl Med 2009; 50: 718-725.

289. Hornung TS, Anagnostopoulos C, Bhardwaj P, et al. Comparison of equilibrium radionuclide ventriculography with cardiovascular magnetic resonance

for assessing the systemic right ventricle after Mustard or Senning procedures for complete transposition of the great arteries. Am J Cardiol 2003; 92:

640-643.

290. Miyagawa M, Mochizuki T, Murase K, et al. Prognostic value of dipyridamole-thallium myocardial scintigraphy in patients with Kawasaki disease.

Circulation 1998; 98: 990-996.

291. Ishikawa Y, Fujiwara M, Ono Y, et al. Exercise- or dipyridamole-loaded QGS is useful to evaluate myocardial ischemia and viability in the patients with

a history of Kawasaki disease. Pediatr Int 2005; 47: 505-511.

292. Caputo GR, Kondo C, Masui T, et al. Right and left lung perfusion: in vitro and in vivo validation with oblique-angle, velocity-encoded cine MR imaging.

Radiology 1991; 180: 693-698.

293. Kim JH, Lee DS, Chung JK, et al. Quantitative lung perfusion scintigraphy in postoperative evaluation of congenital right ventricular outflow tract

obstructive lesions. Clin Nucl Med 1996; 21: 471-476.

294. Fratz S, Hess J, Schwaiger M, et al. More accurate quantification of pulmonary blood flow by magnetic resonance imaging than by lung perfusion

scintigraphy in patients with Fontan circulation. Circulation 2002; 106: 1510-1513.

295. Roman KS, Kellenberger CJ, Farooq S, et al. Comparative imaging of differential pulmonary blood flow in patients with congenital heart disease:

magnetic resonance imaging versus lung perfusion scintigraphy. Pediatr Radiol 2005; 35: 295-301.

296. Sridharan S, Derrick G, Deanfield J, Taylor AM. Assessment of differential branch pulmonary blood flow: a comparative study of phase contrast

magnetic resonance imaging and radionuclide lung perfusion imaging. Heart 2006; 92: 963-968.

297. Varma C, Warr MR, Hendler AL, et al. Prevalence of “silent” pulmonary emboli in adults after the Fontan operation. J Am Coll Cardiol 2003; 41:

2252-2258.

298. Chiu NT, Lee BF, Hwang SJ, et al. Protein-losing enteropathy: diagnosis with (99m)Tc-labeled human serum albumin scintigraphy. Radiology 2001;

219: 86-90.

299. Kiesewetter CH, Sheron N, Vettukattill JJ, et al. Hepatic changes in the failing Fontan circulation. Heart 2007; 93: 579-584.

300. Desai SP, Yuille DL. The unsuspected complications of bacterial endocarditis imaged by gallium-67 scanning. J Nucl Med 1993; 34: 955-957.

文献